[HTML] thieme-connect.com

[HTML][HTML] Anticoagulation in COVID-19: effect of enoxaparin, heparin, and apixaban on mortality

HH Billett, M Reyes-Gil, J Szymanski… - Thrombosis and …, 2020 - thieme-connect.com
Background Mortality in coronavirus disease of 2019 (COVID-19) is associated with
increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has …
被引用次数：191 相关文章

Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.

HH Billett, M Reyes-Gil, J Szymanski… - Thrombosis and …, 2020 - europepmc.org
Background Mortality in coronavirus disease of 2019 (COVID-19) is associated with
increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has …
[HTML] nih.gov

[HTML][HTML] Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality

HH Billett, M Reyes-Gil, J Szymanski… - Thrombosis and …, 2020 - ncbi.nlm.nih.gov
Background Mortality in coronavirus disease of 2019 (COVID-19) is associated with
increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has …

Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.

HH Billett, M Reyes-Gil, J Szymanski… - Thromb …, 2020 - pesquisa.bvsalud.org
BACKGROUND: Mortality in coronavirus disease of 2019 (COVID-19) is associated with
increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has …

Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality

HH Billett, M Reyes-Gil, J Szymanski… - Thrombosis and …, 2020 - einstein.elsevierpure.com
Background: Mortality in coronavirus disease of 2019 (COVID-19) is associated with
increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has …

Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality

HH Billett, M Reyes-Gil, J Szymanski… - Thrombosis and …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Mortality in coronavirus disease of 2019 (COVID-19) is associated with
increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has …
[PDF] portailvasculaire.fr

[PDF][PDF] Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality

HH Billett, M Reyes-Gil, J Szymanski… - Thrombosis and …, 2020 - portailvasculaire.fr
Background Mortality in coronavirus disease of 2019 (COVID-19) is associated with
increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has …

Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin and Apixaban on Mortality

H Billett, M Reyes Gil, J Szymanski, K Ikemura… - Heparin and Apixaban … - papers.ssrn.com
Background: Mortality in coronavirus disease of 2019 (COVID-19) is associated with
increases in prothrombotic parameters, particularly D-dimer levels. Many institutions have …

Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.

HH Billett, M Reyes-Gil, J Szymanski… - Thrombosis and …, 2020 - europepmc.org
Background Mortality in coronavirus disease of 2019 (COVID-19) is associated with
increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has …

Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.

HH Billett, M Reyes-Gil, J Szymanski… - Thromb …, 2020 - pesquisa.bvsalud.org
BACKGROUND: Mortality in coronavirus disease of 2019 (COVID-19) is associated with
increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has …